Life Sciences
Naturally Derived Antimicrobial Compounds as a Potential Means to Combat Milk Spoilage
Author(s): Joseph Yanchar
Does Lactic Acid Bacteria Inhibit Biofilm Formation of Methicillin Resistant Staphylococcus aureus?
Author(s): Caden Wheeler, Ethan Carter, Aidan Nielsen
Measuring the Hydraulic Permeability of Bovine and Human Spinal Vertebral Bony Endplates
Author(s): Dallin Dodds, Ethan Ence
Comparing Quercetin Antiviral Delivery Vehicle Preparation for CMV-Infected Cells.
Author(s): Keira Lentz, Madelyn Friel
Chilling Insights: A Comparative Study of Cancer Tissue Preservation
Author(s): Paige Nelson, Rebecca Bascom,Jacob Harris, Jack Davis, Mackenzie Burr, Jeffrey Okojie
How Metabolic Differences in T Cells from CD5 Deficiency Impacts Anxiety
Author(s): Sophie Daines
Species Comparison of Hemoparasites in Lizards in Southern Utah
Author(s): Karli Nielson, Evie Adams
Role of Perineuronal Nets in Androgen-Induced Masculinization of Female Vocal Pathways of African Clawed Frogs
Author(s): Anuhya Yalavarty, Logan Klar, Cooper Gangi, Tayla Chiang, Berlyn Prue
Validation of the Zebrafish Wolfram Syndrome 2 Model
Author(s): Ashton Gardner, Corbin Arnold
Medically Relevant Bacterial Growth Capacities Influenced by a Variety of Sugar Substitute Solutions
Author(s): Jessica Oram, Tom Vo
Clinician Derived Phenotypic Risk Scores (PheRS): Improving diagnosis timelines for Multiple Sclerosis patients
Author(s): Hailey Whittier, Quinn Beames
Golden Genes: Harnessing Biolistics and RNA Sequencing to Cultivate Drought-Resilient Tomatoes
Author(s): Aubrilin Johnson
GCSF Involvement in Ethanol Dopamine Adaptations
Author(s): Zachary Valentine, Chase Seiter
Role of the Immune System on Ethanol-Associated Cytokine Release and D2R Expression in Mice
Author(s): Alina Svitlana Rodriguez Bezruchko
What Happens When Flies Eat Their Greens? Exploring Diet-Driven Variation in Fly Life History Traits and Microbiota Composition
Author(s): L'Amat Rosales, Sarah J. Gottfredson Morgan, Brittany S. Burnside
Perceived Effectiveness of Study Practices: A Multi-Semester Analysis of Undergraduate Anatomy Students.
Author(s): Samuel Villicana, Mary Nieves
Effects of the Receptor for Advanced Glycation End Products on Successful Arteriovenous Fistula Maturation
Author(s): River Tobias, Yuxia He, Brayden Fairbourn, Amani Oumar, Marina Knysheva
Decoding Spider Identities: An Venom RNA Analysis Using RNA-to-DNA Barcoding Pipeline
Author(s): Alexander Rich
Investigating the effects of MS-222 on cardiovascular function in leopard frogs
Author(s): Tia Dudley, Ty Erickson
Identifying neurons that express dArc1 in Drosophila melanogaster brain
Author(s): Kylie DeNiro
PonixPros: A Novel Greywater Hydroponics System
Author(s): Myshela Todd, Ryan Jamison, Schuyler Baer
Mechanism of Histidine Ammonia Lyase (HAL)
Author(s): Romina Peralta, Isabel Amaro, Jessica Munro
Applying chimeric antigen receptor (CAR) T cell therapy as a potential cure for the B cell-mediated autoimmune disease, Graves’ Disease
Author(s): Kimball Demars, Abigail Cheever, Hunter Lindsay, Chloe Kang
Nicotinic Acetylcholine Receptors
Author(s): Brennan Motes, Benjamin Lewis, Jonny McEntire, Baird Reynolds, Carter Ulrich, Matthew Anderson, Talon Anderson, James Brume, Tanner Carter, Kelton Couperus, Eliza Crossman, Russell Cutler, Tate Giles, Lizzie Goss, Lola Heninger, Alexa Jones, Donald Palmer, Brian Powell, Brandt Stratton, Melissa Terry
Effects of prolactin on β-cell Nr4a1 expression and downstream gene expression
Author(s): Jonathan Hanson
Are you my mother? Investigating genetic relationships among Common murres at the Oregon Coast Aquarium
Author(s): Audrey Domyan, Mathew Harris
Hearing Without Understanding: A Lesion Network Mapping Analysis of Auditory Agnosia
Author(s): Caleb Gardner, Nathan Bastian
Enhancing rangeland restoration with native, early seral Asteraceae species
Author(s): Samuel Leigh
Forb Species Selection for Improved Mine Reclamation
Author(s): Joanna Pincock, Mallory Hinton
Methylation Changes in Blood Following COVID-19 Based on Previously Described Sperm DMRs
Author(s): Alexandra DiLiberto, Ethan McQuhae
Losing the Egg, Keeping the Tooth: Vestigial Egg-Tooth Retention in a Live-bearing Snake
Author(s): Truman Holt, Scott Barton, Sara Harris, Sarah Heinz
Innovations in Organic Pesticides: Enhancing Neem Oil with Essential Oils
Author(s): Isabel Lykken, Katharina Clegg
Prophylactic Treatment of Green Tree Frogs with Chytrid Metabolites
Author(s): Dustin Kolste, Austin Turner
Low dose alcohol enhances dopamine release in the nucleus accumbens via alpha6-containing nicotinic receptors on GABAergic inputs from the ventral tegmental area
Hansen, Wade; Stockard, Alyssa; Anderson, Elizabeth; Yorgason, Jordan; Sudweeks, Sterling; Wu, Jie; Steffensen, Scott (Brigham Young University)
Faculty Advisor: Steffensen, Scott (Family, Home, and Social Sciences; Psychology); Yorgason, Jordan (Life Sciences, Physiology & Developmental Biology); Sudweeks, Sterling (Life Sciences, Physiology & Developmental Biology)
The prevailing view is that enhancement of dopamine (DA) transmission in the mesolimbic underlies the rewarding properties of ethanol (EtOH) and nicotine (NIC). Although the dogma is that EtOH enhancement of DA neural activity contributes to enhancement of DA transmission, DA neurons are not sensitive to rewarding levels of EtOH. However, VTA GABA neurons are sensitive to low-dose EtOH. We have shown previously that EtOH modulation of DA release in the NAc is mediated by α6-containing nicotinic receptors (α6*-nAChRs), that α6*-nAChRs mediate low-dose EtOH effects on VTA GABA neurons and EtOH preference, and α6*-nAChRs may be a molecular target for low-dose EtOH. The aim of this study was to evaluate EtOH effects on VTA GABAergic input to CINs and DA release in the NAc. Using DIO channel rhodopsin-2 (ChR2) viral injections into the VTA of VGAT Cre mice, we found that VTA GABA neurons send an inhibitory projection to CINs, replicating what has been demonstrated by others. Low-dose EtOH (IC50 = 10 mM) decreased optically-evoked IPSCs (oIPSCs) on CINs and enhanced (EC50 = 10 mM) CIN-mediated spontaneous DA release. Surprisingly, oIPSCs on CINs were not blocked by typical GABAA receptor (GABAAR) antagonists, but by GABAR rho-1 antagonists, suggesting involvement of atypical GABARs on CINs that are postsynaptic to VTA GABAergic input. The α6-conotoxin MII blocked the effects of EtOH on spontaneous DA release and optically-evoked DA release in choline acetyltransferase (ChAT) ChR2 mice. Chronic administration of NIC enhanced EtOH consumption in the drink-in-the-dark procedure and EtOH preference in the CPP procedure and concomitantly enhanced expression of α6*-nAChRs in VTA GABA neurons, without affecting other nAChR subunits. Taken together, these findings suggest that VTA GABA neuron inhibitory input to CINs is modulated by α6*-nAChRs and sensitive to low-dose EtOH, which may underlie the rewarding properties of EtOH.
Faculty Advisor: Steffensen, Scott (Family, Home, and Social Sciences; Psychology); Yorgason, Jordan (Life Sciences, Physiology & Developmental Biology); Sudweeks, Sterling (Life Sciences, Physiology & Developmental Biology)
The prevailing view is that enhancement of dopamine (DA) transmission in the mesolimbic underlies the rewarding properties of ethanol (EtOH) and nicotine (NIC). Although the dogma is that EtOH enhancement of DA neural activity contributes to enhancement of DA transmission, DA neurons are not sensitive to rewarding levels of EtOH. However, VTA GABA neurons are sensitive to low-dose EtOH. We have shown previously that EtOH modulation of DA release in the NAc is mediated by α6-containing nicotinic receptors (α6*-nAChRs), that α6*-nAChRs mediate low-dose EtOH effects on VTA GABA neurons and EtOH preference, and α6*-nAChRs may be a molecular target for low-dose EtOH. The aim of this study was to evaluate EtOH effects on VTA GABAergic input to CINs and DA release in the NAc. Using DIO channel rhodopsin-2 (ChR2) viral injections into the VTA of VGAT Cre mice, we found that VTA GABA neurons send an inhibitory projection to CINs, replicating what has been demonstrated by others. Low-dose EtOH (IC50 = 10 mM) decreased optically-evoked IPSCs (oIPSCs) on CINs and enhanced (EC50 = 10 mM) CIN-mediated spontaneous DA release. Surprisingly, oIPSCs on CINs were not blocked by typical GABAA receptor (GABAAR) antagonists, but by GABAR rho-1 antagonists, suggesting involvement of atypical GABARs on CINs that are postsynaptic to VTA GABAergic input. The α6-conotoxin MII blocked the effects of EtOH on spontaneous DA release and optically-evoked DA release in choline acetyltransferase (ChAT) ChR2 mice. Chronic administration of NIC enhanced EtOH consumption in the drink-in-the-dark procedure and EtOH preference in the CPP procedure and concomitantly enhanced expression of α6*-nAChRs in VTA GABA neurons, without affecting other nAChR subunits. Taken together, these findings suggest that VTA GABA neuron inhibitory input to CINs is modulated by α6*-nAChRs and sensitive to low-dose EtOH, which may underlie the rewarding properties of EtOH.
Impaired Glucose Metabolism in Niacin Deficient Transgenic Mice
Allen, Sierra; Meyer-Ficca, Mirella; Wandersee, Miles (Utah State University)
Faculty Advisor: Meyer-Ficca, Mirella (College of Agriculture and Applied Sciences; Animal, Dairy, and Veterinary Sciences Department)
Niacin, a component of vitamin B3, is necessary for the synthesis of nicotinamide adenine dinucleotide (NAD+). NAD+ is an essential coenzyme in several metabolic processes, including those that regulate glucose and fat homeostasis in the body. Niacin is available to humans in its dietary form through foods such as meat, various legumes, nuts and vegetables. Niacin deficiency has been linked to health problems including age-related decline of cognitive abilities, as seen in Alzheimer's disease, and impaired dermal repair. In cases of extreme niacin deficiency, individuals may even develop pellagra, a disease characterized by dermatitis, diarrhea and dementia. Recent studies in niacin deficient mice indicate that niacin deficiency impairs proper glucose metabolism. Compared to mice with adequate niacin levels, niacin deficient mice experience a significant loss of total body weight and body fat and have impaired glucose regulation in response to insulin. We hypothesize that these metabolic defects result from inadequate levels of NAD+ preventing the conversion of lactate to pyruvate in the gluconeogenesis pathway, which in turn results in decreased blood glucose levels. Another potential explanation is that niacin deficiency results in decreased glycogen stores in the liver, also impeding glucose production. To test these hypotheses, we are studying the relationship between dietary niacin and glucose metabolism in a transgenic mouse model with acquired niacin dependency that accurately represents human niacin metabolism. Results of this study will contribute to better understanding of niacin's role in proper glucose metabolism, with important implications for diabetes and other glucose-related diseases, particularly in populations with limited access to quality food.
Faculty Advisor: Meyer-Ficca, Mirella (College of Agriculture and Applied Sciences; Animal, Dairy, and Veterinary Sciences Department)
Niacin, a component of vitamin B3, is necessary for the synthesis of nicotinamide adenine dinucleotide (NAD+). NAD+ is an essential coenzyme in several metabolic processes, including those that regulate glucose and fat homeostasis in the body. Niacin is available to humans in its dietary form through foods such as meat, various legumes, nuts and vegetables. Niacin deficiency has been linked to health problems including age-related decline of cognitive abilities, as seen in Alzheimer's disease, and impaired dermal repair. In cases of extreme niacin deficiency, individuals may even develop pellagra, a disease characterized by dermatitis, diarrhea and dementia. Recent studies in niacin deficient mice indicate that niacin deficiency impairs proper glucose metabolism. Compared to mice with adequate niacin levels, niacin deficient mice experience a significant loss of total body weight and body fat and have impaired glucose regulation in response to insulin. We hypothesize that these metabolic defects result from inadequate levels of NAD+ preventing the conversion of lactate to pyruvate in the gluconeogenesis pathway, which in turn results in decreased blood glucose levels. Another potential explanation is that niacin deficiency results in decreased glycogen stores in the liver, also impeding glucose production. To test these hypotheses, we are studying the relationship between dietary niacin and glucose metabolism in a transgenic mouse model with acquired niacin dependency that accurately represents human niacin metabolism. Results of this study will contribute to better understanding of niacin's role in proper glucose metabolism, with important implications for diabetes and other glucose-related diseases, particularly in populations with limited access to quality food.
Improved Synthetic Bioengineering Production of Polysaccharides and size-specific Oligosaccharides of Low Molecular Weight Heparosan, a Heparin Precursor
Garg, Varun (University of Utah)
Faculty Advisor: Balagurunathan, Kuberan (University of Utah, College of Pharmacy; Medicinal Chemistry)
Heparin is a widely-used blood anticoagulant medicine that is used in surgeries and in treatment of circulatory system illnesses. Heparin is currently harvested from live pigs before they are slaughtered. There are many problems with the current production process of heparin. On a chemical level, the drug can be easily and accidentally altered due to its complex chemical nature. In addition, the environmental impact of the pigs that need to be raised on farms and fed is immense. These reasons and more are why bioengineering approaches towards the artificial synthesis of Heparin need to be researched. One of the major obstacles in the synthesis of heparin is the production of Low Molecular Weight (LMW) Heparosan, a chemical precursor. The research goal is to find methods to increase LMW Heparosan yields to a point where those same yields can be used to conduct further exploration into Heparosan oligosaccharide precursors. These oligosaccharides are useful in further understanding heparin structure-function relationships and will eventually help in the goal to find a commercially viable, cost and time effective method of heparin production. Using shake flask bacterial cultures, LMW Heparosan was produced while adjusting variables such as bacterial density at induction and incubation time to maximize yield. Once a sufficient yield was obtained, oligosaccharide structures spliced from the LMW Heparosan were classified for further research. The initial shake flask experiments showed increased yield and purity of Heparosan for each successive trial. Further work is required to scale up production of LMW Heparosan to a mass-market synthetic Heparin but the research conducted shows a promising method to synthesize and improve yields to make that possible.
Faculty Advisor: Balagurunathan, Kuberan (University of Utah, College of Pharmacy; Medicinal Chemistry)
Heparin is a widely-used blood anticoagulant medicine that is used in surgeries and in treatment of circulatory system illnesses. Heparin is currently harvested from live pigs before they are slaughtered. There are many problems with the current production process of heparin. On a chemical level, the drug can be easily and accidentally altered due to its complex chemical nature. In addition, the environmental impact of the pigs that need to be raised on farms and fed is immense. These reasons and more are why bioengineering approaches towards the artificial synthesis of Heparin need to be researched. One of the major obstacles in the synthesis of heparin is the production of Low Molecular Weight (LMW) Heparosan, a chemical precursor. The research goal is to find methods to increase LMW Heparosan yields to a point where those same yields can be used to conduct further exploration into Heparosan oligosaccharide precursors. These oligosaccharides are useful in further understanding heparin structure-function relationships and will eventually help in the goal to find a commercially viable, cost and time effective method of heparin production. Using shake flask bacterial cultures, LMW Heparosan was produced while adjusting variables such as bacterial density at induction and incubation time to maximize yield. Once a sufficient yield was obtained, oligosaccharide structures spliced from the LMW Heparosan were classified for further research. The initial shake flask experiments showed increased yield and purity of Heparosan for each successive trial. Further work is required to scale up production of LMW Heparosan to a mass-market synthetic Heparin but the research conducted shows a promising method to synthesize and improve yields to make that possible.
Interleukin 10 increases dopamine neuron activity in the ventral tegmental area and increases dopamine release in the nucleus accumbens via reduction of GABA inhibition
Clarke, Eliza; Williams, Stephanie; Payne, Andrew; Obray, J Daniel; Yorgason, Jordan; Steffensen, Scott (Brigham Young University)
Faculty Advisor: Steffensen, Scott (Family, Home, and Social Sciences; Psychology)
Dopamine (DA) transmission is a key player in the rewarding aspects of ethanol as well as ethanol dependence. The current dogma is that DA transmission is increased during ethanol exposure via the inhibition of ventral tegmental area (VTA) GABA neurons and that excitation of VTA GABA neurons during withdrawal results in decreased DA transmission. Microglia, the major neuroimmune effector in the brain, may be a key mediator in this process by releasing cytokines following activation. It is also thought that BDNF may mediate this effect. We evaluated the effect of ethanol on cytokine concentrations in the VTA and nucleus accumbens (NAc), and found that low dose ethanol (1.0 g/kg) decreased interleukin (IL)-10 levels, but high dose ethanol (4.0 g/kg) increased IL-10 levels. We also used standard cell-attached mode electrophysiological techniques to evaluate the effects of select cytokines and BDNF on VTA neuron firing rate in vitro. We found no change in firing rate in response to IL-6 and BDNF, but an increase in firing rate in VTA DA neurons in response to IL-10. Consistent with the changes in firing rate, optically-evoked IPSCs were also found to be decreased in response to IL-10. Ex vivo voltammetry and in vivo microdialysis were done to determine whether IL-10 can directly result in an increase in DA release. Although ex vivo voltammetry showed no change in DA release, IL-10 increased DA release in vivo. These findings suggest that the rewarding and/or addictive effects of ethanol may be mediated by cytokines, specifically the anti-inflammatory cytokine IL-10.
Faculty Advisor: Steffensen, Scott (Family, Home, and Social Sciences; Psychology)
Dopamine (DA) transmission is a key player in the rewarding aspects of ethanol as well as ethanol dependence. The current dogma is that DA transmission is increased during ethanol exposure via the inhibition of ventral tegmental area (VTA) GABA neurons and that excitation of VTA GABA neurons during withdrawal results in decreased DA transmission. Microglia, the major neuroimmune effector in the brain, may be a key mediator in this process by releasing cytokines following activation. It is also thought that BDNF may mediate this effect. We evaluated the effect of ethanol on cytokine concentrations in the VTA and nucleus accumbens (NAc), and found that low dose ethanol (1.0 g/kg) decreased interleukin (IL)-10 levels, but high dose ethanol (4.0 g/kg) increased IL-10 levels. We also used standard cell-attached mode electrophysiological techniques to evaluate the effects of select cytokines and BDNF on VTA neuron firing rate in vitro. We found no change in firing rate in response to IL-6 and BDNF, but an increase in firing rate in VTA DA neurons in response to IL-10. Consistent with the changes in firing rate, optically-evoked IPSCs were also found to be decreased in response to IL-10. Ex vivo voltammetry and in vivo microdialysis were done to determine whether IL-10 can directly result in an increase in DA release. Although ex vivo voltammetry showed no change in DA release, IL-10 increased DA release in vivo. These findings suggest that the rewarding and/or addictive effects of ethanol may be mediated by cytokines, specifically the anti-inflammatory cytokine IL-10.